Role of pharmacists in the Opioid Use Disorder (OUD) crisis
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2019 |
|---|---|
| Erschienen: |
2019 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Research in social & administrative pharmacy : RSAP - 15(2019), 2 vom: 01. Feb., Seite 228-229 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Pringle, Janice L [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 04.04.2019 Date Revised 04.04.2019 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.sapharm.2018.11.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM29078414X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM29078414X | ||
| 003 | DE-627 | ||
| 005 | 20231225065450.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2019 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.sapharm.2018.11.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0969.xml |
| 035 | |a (DE-627)NLM29078414X | ||
| 035 | |a (NLM)30446291 | ||
| 035 | |a (PII)S1551-7411(18)30933-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Pringle, Janice L |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Role of pharmacists in the Opioid Use Disorder (OUD) crisis |
| 264 | 1 | |c 2019 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.04.2019 | ||
| 500 | |a Date Revised 04.04.2019 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Opioid use disorder | |
| 650 | 4 | |a Substance use disorder | |
| 700 | 1 | |a Cochran, Jerry |e verfasserin |4 aut | |
| 700 | 1 | |a Aruru, Meghana |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Research in social & administrative pharmacy : RSAP |d 2005 |g 15(2019), 2 vom: 01. Feb., Seite 228-229 |w (DE-627)NLM166902047 |x 1934-8150 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2019 |g number:2 |g day:01 |g month:02 |g pages:228-229 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.sapharm.2018.11.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2019 |e 2 |b 01 |c 02 |h 228-229 | ||